Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 5ccl.1

Crystal structure of SMYD3 with SAM and oxindole compound

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.50 Å
Oligo State
monomer
Ligands
3 x ZN: ZINC ION(Non-covalent)
1 x SAM: S-ADENOSYLMETHIONINE(Non-covalent)
2 x 4ZW: 2-oxidanylidene-N-piperidin-4-yl-1,3-dihydroindole-5-carboxamide(Non-covalent)
1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Mitchell, L.H. et al., Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor. Acs Med.Chem.Lett. (2016)
Release Date
2015-09-09
Peptides
Histone-lysine N-methyltransferase SMYD3: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Histone-lysine N-methyltransferase SMYD3